Author

E. Nunez-Delicado

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

A. Fernandez-Oliva· 1 shared A. Sakamoto· 1 shared B. Clotet· 1 shared C. R. Esteban· 1 shared C. Risco· 1 shared D. Perez-Zsolt· 1 shared D. Raich-Regue· 1 shared F. Hatanaka· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Fernandez-Oliva

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Therapeutic strategy for spinal muscular atrophy by combining gene supplementation and genome editing

F. Hatanaka, K. Suzuki, K. Shojima, J. Yu, Y. Takahashi, A. Sakamoto, J. Prieto, M. Shokhirev, C. R. Esteban, E. Nunez-Delicado, J. C. I. Belmonte

The paper combines gene supplementation and genome editing to treat spinal muscular atrophy in mice, showing long-term therapeutic benefits.

bioRxiv · Apr 6, 2023Bioengineering

Beta-Cyclodextrins as affordable antivirals to treat coronavirus infection

D. Raich-Regue, R. Tenorio, I. Fernandez-de-Castro, D. Perez-Zsolt, J. Munoz-Basagoiti, M. Sachse, S. Fernandez-Sanchez, M. Gallemi, P. Ortega-Gonzalez, A. Fernandez-Oliva, J. Gabaldon, E. Nunez-Delicado, J. Casas, F. Tarres, J. Vergara-Alert, , C. Risco

The paper identifies beta-cyclodextrins as effective and affordable antivirals against SARS-CoV-2 and other coronaviruses through molecular modeling and in vitro testing.

bioRxiv · Nov 16, 2022Microbiology